The Securities and Exchange Board of India (SEBI), the country’s markets regulator, has granted offshore funds an additional seven months to comply with disclosure requirements around investor data, according to

The Securities and Exchange Board of India’s (Sebi) order barring Zee Entertainment Enterprises promoter Punit Goenka from holding key positions in four Zee group firms and the merged entity with

The Association of National Exchanges Members of India (ANMI) claimed in an email to the Securities and Exchange Board of India (SEBI) on August 17 that the eligibility requirements for audit companies that brokers and clearing entities might use are discriminatory. The email has been examined by Moneycontrol.

The Securities and Exchange Board of India (SEBI) is reportedly planning to make changes to its regulations in order to address concerns related to founders and their family members of

Yatra hosts more than 93,500 hotels on its platform across 1,400 cities and towns in the country. It claims to cater to 700 large corporate customers and more than 46,000

Media reported last month that the company, backed by Canadian billionaire Prem Watsa’s Fairfax Group, aimed to raise around $440 million through an initial public offering. India’s markets regulator has

Eight businesses were fined a total of Rs 51 lakh by Sebi for entertaining in dishonest trading activities in the subject matter of Ejecta Marketing Ltd The declaration came after

Prior to now, NDTV had already informed the stock exchanges that RRPR Holdings Ltd, which owns 29.18% of the broadcaster, had been instructed to transfer all of its equity shares

The proposal comes close on the heels of allegations of front-running at a large fund house. In the discussion paper floated on Friday, Sebi has said it has observed that

It has been alleged that the cabling for NSE’s colo rack was engineered such that Way2Wealth and GKN Securities got the benefit of lower latency, as opposed to other trading

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, India. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. Market regulator Sebi has issued

“When the bits of (unpublished price-sensitive information) that then became selectively available the company abdicated its responsibility to verify and come clean on the unverified information that was floating around,”